Search results for "acids"

showing 10 items of 3520 documents

The human peroxisome in health and disease: The story of an oddity becoming a vital organelle

2013

Abstract Since the first report by Rhodin in 1954, our knowledge on mammalian microbodies/peroxisomes has known several periods. An initial two decades period (1954–1973) has contributed to the biochemical individualisation of peroxisomes as a new class of subcellular organelles (de Duve, 1965). The corresponding research period failed to define a clear role of mammalian peroxisomes in vital functions and intermediary metabolism, explaining why feeling that peroxisomes might be in the human cell oddities has prevailed during several decades. The period standing from 1973 to nowadays has progressively removed this cell oddity view of peroxisomes by highlighting vital function and metabolic r…

Peroxisome Proliferator-Activated ReceptorsDiseaseBiologyCell FractionationMicrobodiesBiochemistryPeroxisomal DisordersOrganellePeroxisomal disorderCentrifugation Density GradientPeroxisomesmedicineAnimalsHumansMicrobodyZellweger SyndromeOrganelle envelopeFatty AcidsGeneral MedicinePeroxisomeLipid Metabolismmedicine.diseaseCell biologyBiochemistryNuclear receptorMetabolic Networks and PathwaysFunction (biology)Biochimie
researchProduct

Toxicological evaluation of peroxisome proliferators. Further cellular and molecular aspects.

1996

International audience

Peroxisome proliferatorChemistryGeneral NeuroscienceCell CycleGuinea PigsFibric AcidsPharmacologyMicrobodiesGeneral Biochemistry Genetics and Molecular BiologyRats[SDV.TOX] Life Sciences [q-bio]/ToxicologyClofibric AcidHistory and Philosophy of ScienceLiverSpecies Specificity[SDV.TOX]Life Sciences [q-bio]/ToxicologyAnimalsHumansComputingMilieux_MISCELLANEOUSCells CulturedAnnals of the New York Academy of Sciences
researchProduct

Phosphorylation of peroxisome proliferator-activated receptor α in rat Fao cells and stimulation by ciprofibrate

1999

The basic mechanism(s) by which peroxisome proliferators activate peroxisome proliferator-activated receptors (PPARs) is (are) not yet fully understood. Given the diversity of peroxisome proliferators, several hypotheses of activation have been proposed. Among them is the notion that peroxisome proliferators could activate PPARs by changing their phosphorylation status. In fact, it is well known that several members of the nuclear hormone receptor superfamily are regulated by phosphorylation. In this report, we show that the rat Fao hepatic-derived cell line, known to respond to peroxisome proliferators, exhibited a high content of PPARalpha. Alkaline phosphatase treatment of Fao cell lysat…

Peroxisome proliferator-activated receptor gammaPhosphataseReceptors Cytoplasmic and NuclearPeroxisome proliferator-activated receptorBiologyMicrobodiesBiochemistryCell LineClofibric AcidmedicineAnimalsEnzyme InhibitorsPhosphorylationPharmacologychemistry.chemical_classificationFibric Acidsfood and beveragesPeroxisomePhosphoric Monoester HydrolasesRatsGene Expression RegulationBiochemistryNuclear receptorchemistryPhosphorylationPeroxisome Proliferatorslipids (amino acids peptides and proteins)Acyl-CoA OxidasePeroxisome proliferator-activated receptor alphaCiprofibrateOxidoreductasesTranscription Factorsmedicine.drugBiochemical Pharmacology
researchProduct

Novel Source of Ubiquitous Phthalates as Analytical Contaminant

1981

Pharmaceutical PreparationsPlasticizersChemistryEnvironmental chemistryPhthalic AcidsPharmaceutical ScienceBlood Chemical AnalysisGas Chromatography-Mass SpectrometryJournal of Pharmaceutical Sciences
researchProduct

Comparative Chemical Compositions of Fresh and Stored Vesuvian PDO "Pomodorino Del Piennolo" Tomato and the Ciliegino Variety

2018

The Vesuvian Piennolo cherry tomato (Lycopersicon esculentum Miller) (PdP) is an old and typical variety grown in the Campania region (Italy). PdP is referred to as a long-storage tomato due to its thick and coriaceous skin that allows long post-harvest storage and it has been granted Protected Designation of Origin (PDO) status since 2009. In this study, the chemical composition, focusing in particular on organic acids, antioxidant molecules and volatile compounds, were investigated in PdP and compared to another typical variety in Campania, the Ciliegino tomato (CIL). Chemical characterization was evaluated for both the CIL and PdP varieties during storage in the same environmental condit…

Pharmaceutical Scienceantioxidants fractionsLycopersiconAntioxidantsArticleAnalytical ChemistryNOlcsh:QD241-441storagechemistry.chemical_compound0404 agricultural biotechnologyPomodorino del Piennolo del Vesuvio; antioxidants fractions; chemical composition; cherry tomato; organic acids; storage; volatile organic compoundsCherry tomatolcsh:Organic chemistrySolanum lycopersicumvolatile organic compoundsDrug Discoveryorganic acidschemical compositionPhysical and Theoretical ChemistryChemical compositionPomodorino del Piennolo del VesuviobiologyChemistryOrganic Chemistryfood and beverages04 agricultural and veterinary sciencesbiology.organism_classification040401 food scienceLycopeneHorticultureChemistry (miscellaneous)Geographic originFruitMolecular Medicinecherry tomato
researchProduct

A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents

2010

BACKGROUND AND PURPOSE Cannabinoid CB1 receptor antagonists reduce food intake and body weight, but clinical use in humans is limited by effects on the CNS. We have evaluated a novel cannabinoid antagonist (AM6545) designed to have limited CNS penetration, to see if it would inhibit food intake in rodents, without aversive effects. EXPERIMENTAL APPROACH Cannabinoid receptor binding studies, cAMP assays, brain penetration studies and gastrointestinal motility studies were carried out to assess the activity profile of AM6545. The potential for AM6545 to induce malaise in rats and the actions of AM6545 on food intake and body weight were also investigated. KEY RESULTS AM6545 binds to CB1 recep…

PharmacologyAM251medicine.medical_specialtyCannabinoid receptormedicine.medical_treatmentAntagonistPharmacologyBiologyEndocrinologyInternal medicinemedicineCannabinoid receptor bindingCannabinoid receptor type 2Cannabinoid receptor antagonistlipids (amino acids peptides and proteins)CannabinoidReceptormedicine.drugBritish Journal of Pharmacology
researchProduct

Influence of N-acetylcysteine on hepatic amino acid metabolism in patients undergoing orthotopic liver transplantation

2001

Experimental treatment with the antioxidant and glutathione precursor N-acetylcysteine (NAC) has been performed in orthotopic liver transplantation (OLT) to reduce reperfusion injury. To investigate the effect of NAC on the hepatic and intestinal amino acid metabolism, intraoperative amino acid exchange rates were studied in liver transplant recipients with high dose NAC treatment (n = 10) and in control patients (n = 9). Treatment with NAC was found to cause a loss of amino acids and increased urea nitrogen release from the liver graft. The net balance of most amino acids was shifted to increased hepatic release or decreased hepatic uptake. The initial cumulative splanchnic release of all …

PharmacologyAcetylcysteinechemistry.chemical_compoundAmino Acids AromaticmedicineHumansUreaSplanchnic CirculationAmino Acidschemistry.chemical_classificationTransplantationbusiness.industryBiological TransportMetabolismGlutathioneFree Radical ScavengersMiddle Agedmedicine.diseaseGlutathioneAmino acidAcetylcysteineLiver TransplantationTransplantationGlutamineProtein catabolismchemistryBiochemistryLiverReperfusion InjurybusinessReperfusion injuryAmino Acids Branched-Chainmedicine.drugTransplant International
researchProduct

Prostanoid receptors of the EP3 subtype mediate inhibition of evoked [3 H]acetylcholine release from isolated human bronchi

1998

1 The release of neuronal [3H]acetylcholine (ACh) from isolated human bronchi after labelling with [3H]choline was measured to investigate the effects of prostanoids. 2 A first period of electrical field stimulation (S1) caused a [3H]ACh release of 320±70 and 200±40 Becquerel (Bq) g−1 in epithelium-denuded and epithelium-containing bronchi respectively (P>0.05). Subsequent periods of electrical stimulation (Sn, n=2, 3, and 4) released less [3H]ACh, i.e. decreasing Sn/S1 values were obtained (0.76±0.09, 0.68±0.07 and 0.40±0.04, respectively). 3 Cumulative concentrations (1–1000 nM) of EP-receptor agonists like prostaglandin E2, nocloprost, and sulprostone (EP1 and EP3 selective) inhibited ev…

PharmacologyAgonistmedicine.medical_specialtybiologyChemistrymedicine.drug_classProstanoidStimulationchemistry.chemical_compoundEndocrinologyInternal medicinebiology.proteinmedicinelipids (amino acids peptides and proteins)CyclooxygenaseProstaglandin E2ReceptorNeurotransmitterAcetylcholinemedicine.drugBritish Journal of Pharmacology
researchProduct

Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE−/−mice and angiogenesis

2015

Background and Purpose Abdominal aortic aneurysm (AAA) is a degenerative vascular disease associated with angiogenesis. Bexarotene is a retinoid X receptor (RXR) ligand with anti-angiogenic activity. Statins also exert anti-angiogenic activity and activate PPARs. Because RXR ligands form permissive heterodimers with PPARs and a single anti-angiogenic drug may not be sufficient to combat the wide array of angiogenic factors produced during AAA, we evaluated the effect of combined low doses of bexarotene and rosuvastatin in a mouse model of AAA.

PharmacologyBexaroteneAngiogenesisPharmacologyRetinoid X receptorBiologymedicine.diseaseenvironment and public healthAngiotensin IINeovascularizationAortic aneurysmRosuvastatin Calciumcardiovascular systemmedicinelipids (amino acids peptides and proteins)Rosuvastatincardiovascular diseasesmedicine.symptommedicine.drugBritish Journal of Pharmacology
researchProduct

The endocannabinoid system: emotion, learning and addiction

2008

The identification of the cannabinoid receptor type 1 (CB1 receptor) was the milestone discovery in the elucidation of the behavioural and emotional responses induced by the Cannabis sativa constituent Delta(9)-tetrahydrocannabinol. The subsequent years have established the existence of the endocannabinoid system. The early view relating this system to emotional responses is reflected by the fact that N-arachidonoyl ethanolamine, the pioneer endocannabinoid, was named anandamide after the Sanskrit word 'ananda', meaning 'bliss'. However, the emotional responses to cannabinoids are not always pleasant and delightful. Rather, anxiety and panic may also occur after activation of CB1 receptors.…

PharmacologyCannabinoid receptorAddictionmedia_common.quotation_subjectmedicine.medical_treatmentMedicine (miscellaneous)AnandamideEndocannabinoid systemPsychiatry and Mental healthchemistry.chemical_compoundnervous systemchemistryCannabinoid receptor type 1medicinelipids (amino acids peptides and proteins)CannabinoidAversive StimulusPsychologyTetrahydrocannabinolNeurosciencemedia_commonmedicine.drugAddiction Biology
researchProduct